Leerink Partners Reiterates a Buy Rating on Akebia Therapeutics (AKBA) With a $7 PT

7 7 月, 2025

One Min Read

10 Views

原文: https://finance.yahoo.com/news/leerink-partners-reiterates-buy-rating-131051176.html

Last Update: 7 7 月, 2025

Written By

Other Articles

Previous

Jefferies Maintains a Buy on Kosmos Energy (KOS)

Next

Craig-Hallum Keeps a Buy Rating on Stagwell Inc. (STGW)

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept